Company

ProQR Therapeutics N.V.

Headquarters: Leiden, Netherlands

Employees: 154

CEO: Mr. Daniel Anton de Boer

NASDAQ: PRQR -3.78%

Market Cap

$164.3 Million

USD as of Jan. 1, 2024

Market Cap History

ProQR Therapeutics N.V. market capitalization over time

Evolution of ProQR Therapeutics N.V. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of ProQR Therapeutics N.V.

Detailed Description

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber's congenital amaurosis 10 disease; QR-421a, which is in phase I/II stellar trial for usher syndrome type 2 and non-syndromic retinitis pigmentosa; QR-1123 that is in phase I/II aurora trial for the treatment of autosomal dominant retinitis pigmentosa; and QR-504a, which is in first clinical trial for the treatment of fuchs endothelial corneal dystrophy. It has a license agreement with Radboud University Medical Center, Inserm Transfert SA, Ionis Pharmaceuticals, Inc., and Leiden University Medical Center, as well as ProQR Therapeutics VIII B.V. for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. ProQR Therapeutics N.V. was incorporated in 2012 and is headquartered in Leiden, the Netherlands.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

ProQR Therapeutics N.V. has the following listings and related stock indices.


Stock: NASDAQ: PRQR wb_incandescent

Stock: BMV: PRQRN wb_incandescent

Stock: FSX: 0PQ wb_incandescent

Details

Headquarters:

Zernikedreef 9

Leiden, 2333 Ck

Netherlands

Phone: 31 88 166 7000